CLINICAL_TRIALS
trial_result
· 2015-07-15
Clinical Trial Update: A Study to Assess the Efficacy of XEN-D0501 in Reducing the Cough Frequency in Patients With COPD [Phase 2]
Summary
Phase 2 trial evaluating XEN-D0501 for reducing cough frequency in Chronic Obstructive Pulmonary Disease has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Xention Ltd | Conditions: Chronic Obstructive Pulmonary Disease | Phase 2 | Status: COMPLETED